Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

• 主要な著者: Qi-An Chen (著者), Wei-Hao Lin (著者), Xiao-Xiang Zhou (著者), Zheng Cao (著者), Xiao-Li Feng (著者), Yi-Bo Gao (著者), Jie He (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2024-02-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...